Pictet Asset Management
AGIO icon

Pictet Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Pictet Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.25M Sell
111,861
-16,953
-13% -$514K ﹤0.01% 819
2026
Q1 		$3.85M Sell
128,814
-76,205
-37% -$2.16M ﹤0.01% 814
2025
Q4 		$5.57M Sell
205,019
-67,142
-25% -$2.36M 0.01% 785
2025
Q3 		$10.7M Sell
272,161
-22,579
-8% -$849K 0.01% 660
2025
Q2 		$9.86M Sell
294,740
-16,041
-5% -$486K 0.01% 657
2025
Q1 		$9.4M Sell
310,781
-43,674
-12% -$1.45M 0.01% 676
2024
Q4 		$11.6M Sell
354,455
-46,394
-12% -$2.18M 0.01% 619
2024
Q3 		$18.3M Sell
400,849
-21,195
-5% -$963K 0.02% 513
2024
Q2 		$18.2M Sell
422,044
-583,582
-58% -$21.1M 0.02% 488
2024
Q1 		$29.3M Buy
1,005,626
+47,346
+5% +$1.27M 0.03% 401
2023
Q4 		$21.3M Buy
958,280
+67,596
+8% +$1.51M 0.02% 475
2023
Q3 		$22M Buy
+890,684
New +$23.6M 0.03% 433

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Pictet Asset Management's AGIO Position: Q2 2026 in Review

Pictet Asset Management reduced its Agios Pharmaceuticals (AGIO) stake by 13% in Q2 2026, selling an estimated $514K and leaving 111,861 shares worth $4.25M. The position accounts for ﹤0.01% of the portfolio, ranked #819.

Pictet Asset Management first reported a position in AGIO in Q3 2023 and has held it in 12 quarters since. The position peaked at $29.3M in Q1 2024. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Pictet Asset Management held 111,861 shares of Agios Pharmaceuticals worth $4.25M as of Q2 2026.
  • Pictet Asset Management sold 16,953 Agios Pharmaceuticals shares in Q2 2026, an estimated $514K.
  • Agios Pharmaceuticals made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #819 holding.
  • Pictet Asset Management first reported a position in Agios Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Agios Pharmaceuticals position peaked at $29.3M in Q1 2024.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.